Fingerprint
Dive into the research topics of 'Randomized, double-blind, placebo-controlled, multicenter phase ii study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically